Wuxi enters Ab sector in partnership with transgenic rat developer OMT
WuXi PharmaTech has formed an antibody discovery partnership with US transgenic animals firm Open Monoclonal Technology (OMT).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs